Meet Pep a free, easy-to-use GLP-1 tracker built specifically for people using Ozempic, Wegovy, Mounjaro, Zepbound, and oral GLP-1 medications for weight loss, diabetes, or metabolic health
Diarrhea Diarrhea is less common than constipation but still affects 5%25% of patients, most often in the first few weeks of therapy
There is limited information about the long-term use of oral glutathione for cosmetic purposes
Once a target is identified, the de-thicketing analysis begins: a systematic, claim-by-claim assessment of every patent in the innovators Orange Book listing and broader portfolio to identify those most vulnerable to P.IV challenge on invalidity (obviousness, anticipation, inadequate written description, enablement) or non-infringement grounds